Skip to content

HyperGlide 104-4127Recalls & reported problems

Micro Therapeutics, Inc. · BALLOON SYSTEM 104-4127 V20 HYPERGLIDE · Class 2

Adverse event reports
7
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00763000294410), received between May 15, 2024 and Dec 10, 2025 — classified as 7 malfunctions.

The most frequently reported specific device problem is “Burst Container or Vessel” (5 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 3 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel5
  • Inflation Problem3
  • Leak/Splash2
  • Deflation Problem1
  • Packaging Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions7

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 10, 2025Burst Container or Vessel; Inflation Problem; Burst Container or Vessel; Inflation Problem

    MEDTRONIC RECEIVED A REPORT THAT DURING IN VITRO TESTING OF THE BALLOON, IT FAILED TO ACHIEVE A NORMAL OCCLUSION STATE; WATER LEAKAGE OCCURRED AT THE TIP. THE PRODUCT WAS REPLACED WITH A MEDTRONIC PRODUCT TO COMPLETE THE PROCEDURE.  THERE WAS NO PATIENT INVOLVEMENT. THE PATIENT HAS A HISTORY OF HYPERTENSION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23767474 ↗
  • MalfunctionMay 29, 2025Burst Container or Vessel; Burst Container or Vessel

    ADDITIONAL INFORMATION WAS RECEIVED REPORTING THE FIRST BALLOON BURST, SO WE REPLACED IT WITH THE SECOND ONE. THE SECOND ONE BURST AGAIN, SO WE REPLACED IT WITH THE THIRD ONE. THEN THE OPERATION WAS SUCCESSFULLY COMPLETED. THE CAUSE OF THE BURSTS WAS NOT DETERMINED. BECAUSE THE BALLOON HAD BEEN DISCARDED IT WAS UNCLEAR WHERE WAS THE BALLOONS' LEAK WAS. NO CARTRIDGE SYRINGES WERE USED, AND IT WAS UNCLEAR WHAT SYRINGES WERE USED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22107004 ↗
  • MalfunctionMay 29, 2025Burst Container or Vessel; Packaging Problem; Burst Container or Vessel; Packaging Problem

    MEDTRONIC RECEIVED A REPORT THAT A HOLE WAS DETECTED IN THE HYPERGLIDE BALLOON WHILE PREPPING. THE DEVICE NEVER WENT INTO THE PATIENT. NO PATIENT SYMPTOMS OR COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22105080 ↗
  • MalfunctionMay 19, 2025Leak/Splash; Leak/Splash

    MEDTRONIC RECEIVED A REPORT THAT AFTER OPENING THE PACKAGE AND HYDRATING, THE BALLOON WAS FOUND TO BE LEAKING WATER. IT WAS REPLACED AND THE SURGERY WAS COMPLETED. NO PATIENT SYMPTOMS OR COMPLICATIONS WERE ASSOCIATED WITH THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22042911 ↗
  • MalfunctionDec 4, 2024Burst Container or Vessel; Deflation Problem; Inflation Problem; Burst Container or Vessel; Deflation Problem; Inflation Problem

    IT WAS REPORTED THAT DURING A NEUROVASCULAR PROCEDURE INVOLVING THE HYPERGLIDE 4.0 X 20 MM 4 MM TIP SYSTEM, THE OCCLUSION BALLOON RUPTURED BEFORE REACHING ITS MAXIMUM VOLUME. THE BALLOON, INITIALLY INFLATED WITH A 1:1 CONTRAST AGENT AND ANTICOAGULANT WATER MIXTURE, SUDDENLY DEFLATED WHEN INFLATED TO THE STANDARD CAPACITY WITH A CARTRIDGE SYRINGE. ATTEMPTS TO REINFLATE THE BALLOON WITH THE SAME MIXTURE WERE UNSUCCESSFUL, AND IT WAS SUSPECTED TO HAVE BURST. UPON REMOVAL FROM THE BODY, THE BURST WAS CONFIRMED. THE PROCEDURE INVOLVED ADDRESSING A LEFT INTERNAL CAROTID CAVERNOUS FISTULA, WITH BILATERAL PUNCTURE PERFORMED. THE LEFT SIDE USED AN 8F 95CM GUIDING CATHETER, AND THE RIGHT SIDE USED A 6F 105CM JOHNSON & JOHNSON ENVOY DA. TWO ECHELON10S WERE USED, ONE FOR EMBOLIZATION COILS AND THE OTHER FOR GLUE INJECTION. AFTER THE INITIAL BALLOON FAILURE, A REPLACEMENT HYPERGLIDE-4-20 BALLOON OF THE SAME MODEL AND SIZE WAS USED, WHICH INFLATED SUCCESSFULLY AND EFFECTIVELY SEALED THE CAVERNOUS SINUS FISTULA. THE PROCEDURE CONTINUED WITH THE USE OF ECHELON 10 COILS, AXIUM-22-50-3D COILS, BRIDGE COILS, AND ONYX INJECTIONS, WITH ANGIOGRAPHYCONFIRMING THE COMPLETE BLOCKAGE OF THE FISTULA. THE BLO

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20849230 ↗
  • MalfunctionJul 10, 2024Inflation Problem; Leak/Splash; Inflation Problem; Leak/Splash

    MEDTRONIC RECEIVED A REPORT THAT THE HYPERGLIDE BALLOON CATHETER WAS FOUND LEAKING AND COULD NOT BE INFLATED, TWO ECHELON MICROCATHETERS ENCOUNTERED RESISTANCE, AND AN APOLLO CATHETER ENCOUNTERED RESISTANCE WITH THE MIRAGE GUIDE WIRE AND THE TIP BECAME DETACHED. THE PATIENT WAS UNDERGOING MINIMALLY INVASIVE NEURO-INTERVENTION FOR TREATMENT OF A DURAL ARTERIOVENOUS FISTULA. THE ACCESSED VESSEL WAS THE FEMORAL ARTERY WITH A DIAMETER OF 9 MM, THE RADIAL ARTERY WITH A DIAMETER OF 2.7 MM AND AN UNKNOWN VEIN WITH A DIAMETER OF 10 MM. IT WAS NOTED THE PATIENT'S VESSEL TORTUOSITY WAS MODERATE. IT WAS REPORTED THAT THE RADIAL ARTERY WAS PUNCTURED, AND THE BIOTECH 6F 90CM LONG SHEATH REACHED THE TARGET VESSEL FOR TREATMENT. THE HYPERGLIDE BALLOON WAS OPENED IN VITRO, HYDRATED, AND THEN INFLATED AND DEFLATED AS USUAL. HOWEVER, DURING THE INFLATION, IT WAS FOUND THAT THE BALLOON WAS LEAKING WATER AND COULD NOT BE INFLATED, AND THERE WAS ALSO WATER BACKFLOW AT THE PROXIMAL END OF THE BALLOON CATHETER. AFTER RE-HYDRATION, THE INFLATION AND DEFLATION IT WAS TRIED AGAIN, BUT THE PREVIOUS SITUATION STILL OCCURRED. IN DESPERATION, THE SURGEON DARED NOT USE THE PRODUCT AND REPORTED THE COMPLAINT. IT

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19712460 ↗
  • MalfunctionMay 15, 2024Burst Container or Vessel; Burst Container or Vessel

    MEDTRONIC RECEIVED A REPORT THAT DURING A PIPELINE SURGERY, A BALLOON WAS USED FOR POST-PROCESSING. AFTER THE BALLOON WAS IN PLACE, A SYRINGE WAS USED TO EXPAND IT NORMALLY. AFTER EXPANSION, IT WAS FOUND THAT THE BALLOON WAS LEAKING AND DAMAGED, SO THE BALLOON WAS REPLACED. THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS ASSOCIATED WITH THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19325274 ↗

Other Catheter, intravascular occluding, temporary devices

All Catheter, intravascular occluding, temporary devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.